Cholinergic receptor, nicotinic, alpha 7 as a target molecule of Arctic mutant amyloid β  

作　　者：Naoya Sawamura Ye Ju Toru Asahi 

机构地区：[1]Faculty of Science and Engineering, Waseda University [2]Research Organization for Nano & Life Innovation, Waseda University

出　　处：《Neural Regeneration Research》2018年第8期1360-1361,共2页中国神经再生研究（英文版）

基　　金：supported by a grant KAKENHI 15K06786;the Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program(COI STREAM)of the Ministry of Education,Culture,Sports,Science and Technology(MEXT),Japan

摘　　要：Alzheimer’s disease（AD）is a progressive cognitive disorder that develops predominantly in elderly patients and is characterized by cognitive impairments affecting memory,learning,and attention（Selkoe,2002）.Alzheimer’s disease（AD）is a progressive cognitive disorder that develops predominantly in elderly patients and is characterized by cognitive impairments affecting memory,learning,and attention（Selkoe,2002）.

关 键 词：Cholinergic receptor alpha 7 as a target molecule of Arctic mutant amyloid NICOTINIC AD 

分 类 号：R749.16[医药卫生—神经病学与精神病学]